MedTech News
Paper-based devices diagnose malaria in asymptomatic people during field test
Devices made with cheap strips of paper have outperformed two other testing methods in detecting malaria infection in asymptomatic people in Ghana—a diagnostic advance that could accelerate efforts to eliminate the disease, researchers say.
Australian Company Launches World’s First Smart Hearing Implant System
Groundbreaking innovation redefines hearing care with intelligent, connected implant technology
GI Windows wins FDA nod for magnet tech
GI Windows Surgical announced today that it received FDA 510(k) clearance for its Flexagon self-forming magnet technology.
AiMIFY™ AI MRI Software Earns CE Mark, Backed by Bracco and Subtle Medical
AI-powered solution aims to improve image quality and efficiency in MRI workflows across Europe
InspireMD wins CE Mark approval for CGuard Prime
InspireMD today announced it received CE Mark approval for its CGuard Prime carotid stent system for the prevention of stroke.
AI tool analyzes blood DNA fragments for faster, affordable cancer monitoring
Scientists from the A*STAR Genome Institute of Singapore (A*STAR GIS) have developed a new artificial intelligence (AI)-based method called “Fragle” that makes tracking cancer easier and faster using blood tests.
First-of-its-kind device profiles newborns’ immune function
The BiophysicaL Immune Profiling for Infants (BLIPI) profiles an infant’s immune system in under 15 minutes, using just a single drop of blood.
MolecuLight® Imaging Significantly Improves Outcomes and Cuts Costs for Deep Sternal Wound Infections in Taiwan Study; Signals Expansion into Surgical Applications
TORONTO and TAIPEI, June 12, 2025 /PRNewswire/ — MolecuLight Inc., a global pioneer in point-of-care fluorescence imaging for wound care, and its Taiwanese distributor, Healtdeva Company Ltd., congratulate researchers at Shuang-Ho Hospital in Taipei, Taiwan on their publication of groundbreaking findings using MolecuLight. The clinical study demonstrates the transformative impact of MolecuLight’s i:X® device on the management of deep sternal wound infections (DSWI), showcasing significantly improved patient outcomes alongside cost savings and reduced burden on the healthcare system.